Clinical Trial Update: Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pembrolizumab in combination with odetiglucan for liver-predominant metastatic colorectal cancer; the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Odetiglucan
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Colorectal Adenocarcinoma Metastatic in the Liver | Phase 2 | Status: RECRUITING